TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23505993

Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral group therapy for anxiety
Number of subjects: 84
Study: 21516035

Group type: EXPERIMENTAL
Intervention: Deliberate Practice (DP) group
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 19318674

Group type: EXPERIMENTAL
Intervention: Shortened AMP challenge
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard AMP challenge
Number of subjects: 18

Group type: COMPARATOR
Intervention: Repeated shortened AMP challenges
Number of subjects: 18
Study: 16714767

Group type: EXPERIMENTAL
Intervention: Conservative fluid management strategy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Liberal fluid management strategy
Number of subjects: 1000
Study: 15449262

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation
Number of subjects: 1454

Group type: COMPARATOR
Intervention: No bowel preparation
Number of subjects: 1454

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation with polyethylene glycol (PEG)
Number of subjects: 1454

Group type: EXPERIMENTAL
Intervention: Other bowel preparations
Number of subjects: 1454
Study: 11722295

Group type: EXPERIMENTAL
Intervention: Visual estimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goniometry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Still photography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hand behind back reach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stand and reach
Number of subjects: 0
Study: 9143391

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-1 alpha (rhuIL-1 alpha) at doses of 0.1-10 micrograms/m2 for 4 days by subcutaneous injection before ICF chemotherapy
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-1 alpha (rhuIL-1 alpha) administered after ICE chemotherapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group receiving standard chemotherapy without rhuIL-1 alpha
Number of subjects: 27
Study: 8106800

Group type: EXPERIMENTAL
Intervention: Chromium treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 25
Study: 3115350

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 31961303

Group type: EXPERIMENTAL
Intervention: TPHD-LAMP for T. pallidum
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: TPHD-LAMP for H. ducreyi
Number of subjects: 293
Study: 30167701

Group type: EXPERIMENTAL
Intervention: Supraglottic airway device (SGA)
Number of subjects: 9296

Group type: COMPARATOR
Intervention: Tracheal intubation (TI)
Number of subjects: 9296
Study: 27917213

Group type: EXPERIMENTAL
Intervention: Early skin-to-skin contact (SSC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (radiant warmer)
Number of subjects: 200
Study: 25005193

Group type: EXPERIMENTAL
Intervention: Primary pterygium surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Recurrent pterygium surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison at 1 month after surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison at 1 week after surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison at 3 months after surgery
Number of subjects: 40
Study: 22031621

Group type: EXPERIMENTAL
Intervention: BMS‐690514, 200 mg after a high‐fat meal (951 kcal, 52% fat)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: BMS‐690514, 200 mg after a light meal (336 kcal, 75% carbohydrate)
Number of subjects: 43

Group type: COMPARATOR
Intervention: BMS‐690514, 200 mg while fasting
Number of subjects: 43
Study: 20533105

Group type: EXPERIMENTAL
Intervention: Intensive sucralfate therapy plus conventional therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 15
Study: 18466925

Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg/day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined treatment (Estrogen 0.625 mg/d plus buspirone)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Buspirone only)
Number of subjects: 18
Study: 15972174

Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mayo repair
Number of subjects: 50

Group type: COMPARATOR
Intervention: Onlay repair with mesh
Number of subjects: 50
Study: 12142810

Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg, maximum dose of 20 mg) with IV meperidine (2 mg/kg, maximum dose of 100 mg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Oral diazepam (0.3 mg/kg, maximum dose of 10 mg) with IV meperidine (2 mg/kg, maximum dose of 100 mg)
Number of subjects: 154
Study: 9927110

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (weekly doses subcutaneously on Days -21, -14, -7, and day of surgery)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Preoperative autologous blood donation (PAD)
Number of subjects: 490
Study: 8667039

Group type: EXPERIMENTAL
Intervention: Cefodizime 1 g i.m. qD (Group A)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Cefodizime 1 g i.m. BID (Group B)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Ceftriaxone 1 g i.m. qD (Group C)
Number of subjects: 238
Study: 2201431

Group type: COMPARATOR
Intervention: Doxorubicin (70 mg/m2 intravenously)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Doxorubicin (70 mg/m2 intravenously) and Vindesine (3 mg/m2 intravenously)
Number of subjects: 298
Study: 621282

Group type: EXPERIMENTAL
Intervention: Ambient room temperature and water content
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Body temperature and ambient water content
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ambient room temperature fully saturated
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Body temperature fully saturated air
Number of subjects: 8
Study: 30926686

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conscious Sedation (CS)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Direct aspiration technique
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Stent retriever
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: GA
Number of subjects: 128

Group type: COMPARATOR
Intervention: CS
Number of subjects: 128
Study: 28002882

Group type: EXPERIMENTAL
Intervention: LC28-0126 (0.3, 1, 3, 10, 25, 50, 100, or 200 mg)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: LC28-0126 (0.3 to 200 mg)
Number of subjects: 89
Study: 26032952

Group type: EXPERIMENTAL
Intervention: Low dose (1.5 mg NES/0.5 mg E2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Medium dose (3.0 mg NES/1.0 mg E2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High dose (4.5 mg NES/1.5 mg E2)
Number of subjects: 18
Study: 23602417

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) with standard rehabilitation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard inpatient rehabilitation program
Number of subjects: 41
Study: 21723049

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: American Lung Association's freedom from smoking (FFS)
Number of subjects: 88
Study: 19187623

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 1973

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 1973
Study: 16719728

Group type: EXPERIMENTAL
Intervention: 4 NRT ads
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: 4 Zyban ads
Number of subjects: 492

Group type: COMPARATOR
Intervention: 4 ads promoting nonpharmacologic cessation services (quitline ads)
Number of subjects: 492
Study: 15146339

Group type: EXPERIMENTAL
Intervention: Combined pharmaco- and psychotherapy (COMBI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interpersonal psychotherapy
Number of subjects: 0
Study: 11368131

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg followed by misoprostol 400 microg 6-8 hours later (Group 1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Mifepristone 600 mg followed by misoprostol 400 microg 48 hours later (Group 2)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard regimen (Group 2)
Number of subjects: 86
Study: 11203554

Group type: EXPERIMENTAL
Intervention: Barrier membrane placement (e-PTFE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No barrier membrane placement
Number of subjects: 12
Study: 8678348

Group type: EXPERIMENTAL
Intervention: E-speed film
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Non-enhanced RVG-S
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RVG-S with steep gradient enhancement (X-function)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Niobium filtration
Number of subjects: 20

Group type: COMPARATOR
Intervention: CCD-based devices
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Contrast enhancement of digital images (RVG-S X-function)
Number of subjects: 20
Study: 1360776

Group type: EXPERIMENTAL
Intervention: 0.88 mg/kg oxatomide
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg oxatomide
Number of subjects: 9
Study: 6400576

Group type: EXPERIMENTAL
Intervention: Topical 1% prednisolone acetate
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Subconjunctival methylprednisolone sodium succinate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Untreated group (control)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Steroid treated group (intervention)
Number of subjects: 39
Study: 29768328

Group type: EXPERIMENTAL
Intervention: Etomidate-midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol-midazolam
Number of subjects: 0
Study: 27192347

Group type: EXPERIMENTAL
Intervention: Risk calculator data
Number of subjects: 779

Group type: COMPARATOR
Intervention: Control group (clinical vignettes alone)
Number of subjects: 779
Study: 25060015

Group type: EXPERIMENTAL
Intervention: Intralesion (IL) bolus abciximab
Number of subjects: 450

Group type: COMPARATOR
Intervention: No abciximab
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 450

Group type: COMPARATOR
Intervention: No aspiration
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Shorter delay to reperfusion (<3 hours)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Longer delay to reperfusion (≥3 hours)
Number of subjects: 450
Study: 22309242

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg/day)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fenofibrate (160 mg/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: COMPARATOR
Intervention: Obese individuals (baseline comparison)
Number of subjects: 28
Study: 20089730

Group type: EXPERIMENTAL
Intervention: Blood n‐3 fatty acids (eicosapentaenoic acid)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Blood n‐6 fatty acids (arachidonic acid)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Blood trans fatty acids (total trans 18:1)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Blood monounsaturated fatty acids (oleic acid)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Blood saturated fatty acids
Number of subjects: 61
Study: 17896781

Group type: EXPERIMENTAL
Intervention: Ductal carcinoma in situ component or poor nuclear grade tumors
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Tumors arising in radial scars, tubular histologic type, moderate/marked tumor stroma
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Nuclear grade
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Lymphatic tumor extension
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Local breast irradiation and adjuvant therapy
Number of subjects: 638
Study: 16116154

Group type: EXPERIMENTAL
Intervention: Intensive alkylator-based induction chemotherapy with or without autologous bone marrow transplantation (ABMT) with or without 13 cis-retinoic acid.
Number of subjects: 43
Study: 12169044

Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5mg daily with erythromycin 500mg every 8 hours for 10 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5mg daily with erythromycin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Desloratadine 7.5mg daily with placebo
Number of subjects: 24
Study: 10575337

Group type: EXPERIMENTAL
Intervention: Inhaled glutathione (600 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8543722

Group type: EXPERIMENTAL
Intervention: Psychodynamic-interpersonal (PI) therapy
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) therapy
Number of subjects: 114
Study: 2085111

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 130

Group type: COMPARATOR
Intervention: Trimethoprim
Number of subjects: 130
Study: 29774647

Group type: EXPERIMENTAL
Intervention: Fetal movement counting (experimental group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Continual routine monitoring (control group)
Number of subjects: 110
Study: 28644314

Group type: EXPERIMENTAL
Intervention: Prone starting position
Number of subjects: 181

Group type: COMPARATOR
Intervention: Left-sided starting position
Number of subjects: 181
Study: 27170445

Group type: EXPERIMENTAL
Intervention: BAT 1200 μg via DPI-D
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BAT 1200 μg via DPI-E without a lactose-filled second strip
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BAT 1200 μg via DPI-E with a lactose-filled second strip
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BAT/FF 1200/300 μg via DPI-E
Number of subjects: 48

Group type: COMPARATOR
Intervention: FF 300 μg via DPI-E with a lactose-filled second strip
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BAT/FF 900/300 μg via DPI-E
Number of subjects: 48
Study: 24526257

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Prednisolone (2.0 mg/kg/d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 19
Study: 22842891

Group type: EXPERIMENTAL
Intervention: Combined health and employment promotion intervention (AmigA)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study: 20207157

Group type: EXPERIMENTAL
Intervention: Solar radiation, broadband UVB, or use of sunbeds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Broadband UVB phototherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UV radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sun or sunbeds
Number of subjects: 0
Study: 18819024

Group type: EXPERIMENTAL
Intervention: Depressed patients
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study: 15556964

Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 3 mg (high-volume, low-concentration solution)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 3 mg (low-volume, high-concentration solution)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Overall data for epidural diamorphine
Number of subjects: 62
Study: 12824105

Group type: EXPERIMENTAL
Intervention: Problem-based learning case featuring spirituality as a prominent theme
Number of subjects: 192

Group type: COMPARATOR
Intervention: Problem-based learning cases with no mention of spirituality
Number of subjects: 192
Study: 10566877

Group type: EXPERIMENTAL
Intervention: Phytosterol ester-enriched margarine (40 g containing 8.6 g vegetable oil phytosterol)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control margarine (40 g)
Number of subjects: 24
Study: 8712078

Group type: EXPERIMENTAL
Intervention: Vitrectomy with autoserum instillation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vitrectomy alone (without autoserum)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Reoperation with autoserum
Number of subjects: 34
Study: 1853989

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Imipramine with clinical management
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo with clinical management
Number of subjects: 239
Study: 6881974

Group type: EXPERIMENTAL
Intervention: Levamisole group (three-drug regimen: 5-FU, Adriamycin, and Levamisole)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (two-drug regimen: 5-FU and Adriamycin)
Number of subjects: 81
Study: 31439467

Group type: EXPERIMENTAL
Intervention: Total Body Weight (TBW) dosing, 1.22 mL/kg
Number of subjects: 280

Group type: COMPARATOR
Intervention: Lean Body Weight (LBW) dosing, 1.66 mL/kg for women and 1.52 mL/kg for men
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TBW dosing
Number of subjects: 280

Group type: COMPARATOR
Intervention: LBW dosing
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: TBW and LBW dosing
Number of subjects: 280
Study: 30845095

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 or 30 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (no Dexamethasone)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Dexamethasone (30 mg)
Number of subjects: 63
Study: 29023215

Group type: EXPERIMENTAL
Intervention: Monthly Denosumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zoledronic Acid (ZA) every 3 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monthly Zoledronic Acid (ZA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 0
Study: 26511380

Group type: EXPERIMENTAL
Intervention: Patellar tendon strap during squatting at 30°
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Patellar tendon strap during squatting at 60°
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unstrapped condition
Number of subjects: 20
Study: 25581657

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 63
Study: 23020162

Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 991

Group type: COMPARATOR
Intervention: Lapatinib plus capecitabine
Number of subjects: 991
Study: 19401207

Group type: EXPERIMENTAL
Intervention: High-pass fractal masker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-pass checkerboard masker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dichoptic presentation
Number of subjects: 0
Study: 17890830

Group type: EXPERIMENTAL
Intervention: Quality improvement (QI) programs involving medication or psychotherapy
Number of subjects: 945

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 945
Study: 15126132

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide (2.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11669431

Group type: EXPERIMENTAL
Intervention: 7.5 mg hyperbaric bupivacaine with added fentanyl 20 microg (group BF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 12.5 mg hyperbaric bupivacaine alone (group B)
Number of subjects: 42
Study: 9481395

Group type: EXPERIMENTAL
Intervention: Mesh herniorrhaphy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Shouldice herniorrhaphy
Number of subjects: 105
Study: 7985742

Group type: EXPERIMENTAL
Intervention: CQ/CQ (sulfadoxine-pyrimethamine and/or chloroquine) for at least 45 days prior to delivery
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: SP/CQ (treatment dose of sulfadoxine-pyrimethamine followed by weekly chloroquine prophylaxis)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: SP/SP (two-dose sulfadoxine-pyrimethamine regimen)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: CQ/CQ during peak transmission season (April to July)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: SP/CQ during peak transmission season (April to July)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: SP/SP during peak transmission season (April to July)
Number of subjects: 159
Study: 2510618

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 281

Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 281
Study: 31732771

Group type: EXPERIMENTAL
Intervention: Active Voiding Trials (AVT)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Passive Voiding Trials (PVT)
Number of subjects: 274
Study: 30136704

Group type: EXPERIMENTAL
Intervention: Continuous Renal Replacement Therapy (CRRT) in addition to conventional therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: CRRT
Number of subjects: 92
Study: 26968939

Group type: EXPERIMENTAL
Intervention: Micro-randomised trial
Number of subjects: 128
Study: 25623903

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg daily)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 23042974

Group type: EXPERIMENTAL
Intervention: Daclizumab (DZB) + Mycophenolate mofetil (MMF)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Daclizumab (DZB) - Mycophenolate mofetil (MMF)
Number of subjects: 126
Study: 21107264

Group type: EXPERIMENTAL
Intervention: Masimo 'Radical 7'
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nellcor 'N 600'
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 52
Study: 18363314

Group type: EXPERIMENTAL
Intervention: Methylphenidate (mean daily dose of 36.7 +/- 11.2 mg over > or = 26 days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 34
Study: 16209971

Group type: EXPERIMENTAL
Intervention: Dietitian education (2 counseling sessions)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care (self-help literature)
Number of subjects: 47
Study: 12029450

Group type: EXPERIMENTAL
Intervention: Colloid infusion
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control (no colloid infusion)
Number of subjects: 131
Study: 10999121

Group type: EXPERIMENTAL
Intervention: EPO therapy (40 U/kg biweekly for 6 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not receiving EPO)
Number of subjects: 40